Prime Therapeutics welcomes Chris Knibb as Chief Financial Officer

Promotes Dave Schlett to executive vice president

September 28, 2021

EAGAN, Minn.Chris Knibb, an accomplished finance executive with more than 25 years of financial and business leadership, has joined Prime Therapeutics LLC (Prime), as its new chief financial officer (CFO). In this role, Knibb will oversee Prime’s corporate finance area, including treasury and internal audit, supply chain economics, financial planning and analysis, as well as controller functions.

Chris KnibbKnibb’s career has spanned a variety of industries including health care. He recently held the CFO position at SOC Telemed, an acute-care telemedicine company, and previously served as Express Scripts’ senior vice president of finance and chief accounting officer. He has also served in various financial leadership roles over the years for several public and privately held companies in technology, energy, and natural resources space.

Knibb (pictured at left) is a certified public accountant (CPA), holds a Bachelor of Arts degree, plus completed post-graduate courses in accounting from the University of South Florida, Tampa, Fla. Knibb is also a military veteran, having served in the United States Army.

Dave SchlettDave Schlett (pictured at right), who has served as Prime’s CFO the past two years, has also been promoted to an expanded role as executive vice president (EVP) – chief client relationship and administrative officer. Schlett joined Prime in January 2020 and brought expertise in finance, strategic planning, business development, and other business aspects, including those unique to the PBM industry. In his new role, he will continue to lead finance, pricing, underwriting, and analytics as well as oversee Prime’s growth and retention efforts.

“We are so fortunate to have the expertise of these two, highly-regarded health care leaders at Prime,” said Prime’s President and CEO Ken Paulus. “Both have a high level of business acumen and strong financial backgrounds which will serve Prime well in the future.”

Related news

Press releases

July 21, 2022

Prime Therapeutics recognized as a Disability Equality Index® Best Place to Work for Disability Inclusion

EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) is…

Press releases

July 18, 2022

Prime Therapeutics’ intervention pilot for opioid users improves outcomes

EAGAN, Minn. – During the COVID-19 pandemic, drug overdoses killed over 107,000 Americans…

Press releases

June 2, 2022

Prime Therapeutics finds $1.1 million waste reduction opportunity with medically integrated dispensing compared to central specialty pharmacy

EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) analyzed…